Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Books
  • Manufacturing
  • Health
  • Technology
  • Financial
  • Entertainment
ncarol.com

Fuse Oncology Closes Funding Round with Support from Leading Health Systems in the Southern U.S.
ncarol.com/10223769

Trending...
  • USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
  • Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
  • Sky Quarry Restarts Nevada's Only Crude Oil Refinery — A Major New Chapter Begins in This Highly Lucrative sector for N A S D A Q: SKYQ
GREENSBORO, N.C., June 1, 2023 ~ Fuse Oncology, an oncology software solutions company, has announced the successful closing of its oversubscribed Series A. Cone Health Ventures and Northeast Georgia Health Ventures (NGHV) were among the largest contributors to the round. The investments will be used to accelerate the expansion of Fuse Oncology's first commercial product, S!GNAL, and develop additional solutions in the radiation oncology market.

James Bauler, CEO of Fuse Oncology, Inc., expressed his gratitude for the investors' enthusiasm and interest in their product. "We are grateful for the interest and enthusiasm of investors who understand the significant impact of our product and our potential to thrive in the market," said Bauler.

Fuse Oncology was spun out of Cone Health and signed its first revenues in quarter one of 2022. Their technology is designed to address key challenges that face radiation oncology departments by automatically identifying and tracking missing documentation, incomplete tasks and orders, as well as wrong charges entered.

More on ncarol.com
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
  • "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
  • Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
  • Indianapolis Criminal Defense Firm Rigney Law LLC Relaunches Criminal Law Podcast "Tales from the Brown Desk"

John Miller, chief investment officer at Cone Health, expressed his confidence in leading this funding round to support Fuse Oncology's growth. "Fuse has made phenomenal progress in establishing a foothold in the radiation oncology market," said Miller. "We are confident in leading this funding round to support their growth and help expand their reach."

S!GNAL technology from Fuse Oncology catches issues before they materialize to drastically improve revenue cycle and clinical staff workflows. By minimizing mistakes in coding and documentation processes, it has uncovered substantial lost revenues for providers. Additional solutions from Fuse address challenges in patient engagement cycles to reduce average time to treatment.

Stuart Burri, MD, chairman of radiation oncology at Levine Cancer Institute, president of Southeast Radiation Oncology Group (SERO), and an early investor continues to support Fuse Oncology's advancement. "Fuse's rapid expansion in local radiation oncology centers has changed the way we're thinking about business," said Dr Burri. "It's exciting to reimagine a seamless workflow and data experience between radiation oncology departments and health systems."

Fuse Oncology's Series A closing marks a major milestone for them as they continue their mission to make rad onc departments more efficient while supporting substantial growth in volumes and revenues throughout 2023.
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • 2026 Triangle Parade of Homes Features Over 300 Homes
  • "Next Friday" Star Mike Epps Hits Cherokee as KayeDinero Drops "Cherokee"
  • P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
  • Travel Season Turns to the Smokies as KayeDinero Turns Cherokee Into a Song
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Cabinet Revolution Expands Affordable Cabinet Options for High Country Homes
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Shuttle Buddy Announces Amazon Partnership to Launch Workforce Express in North Carolina
  • Inlow Upholstery Helps Cleveland County Homeowners Refresh Furniture with Custom Upholstery
  • Birthstones Are Having a 2026 Moment. KayeDinero's "Aquamarine" Began With Her Grandmother
  • Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
  • Virtually Tour Heritage at South Brunswick's Resort-Style Living - Experience Indoor and Outdoor Amenities at Your Fingertips
_catLbl0 _catLbl1

Popular on ncarol.com

  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing - 176
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 159
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 149
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million - 133
  • Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering - 123
  • MommyAndMe.club Expands Parent-Child Class Directory to All 50 States and Washington, D.C - 109
  • Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB) - 108
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 108
  • Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States - 102
  • ChargeOn Announces Conversational Payment Management Solution

Similar on ncarol.com

  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
  • Advantage Newspaper Consultants Celebrates 30 Years of Serving the Newspaper Industry
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute